{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:10:46Z","timestamp":1789686646354,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart &amp; Lung"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.hrtlng.2019.10.003","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T08:13:14Z","timestamp":1571818394000},"page":"158-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic value of hemodynamics and comorbidities in pulmonary hypertension due to advanced heart failure"],"prefix":"10.1016","volume":"49","author":[{"given":"Ruilin","family":"Quan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2019.10.003_bib0001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0002","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jchf.2015.01.013","article-title":"Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction","volume":"3","author":"Al-Naamani","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0003","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0004","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ehf2.12284","article-title":"Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure","volume":"5","author":"Kumarasinghe","year":"2018","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1751-7133.2011.00234.x","article-title":"Pulmonary hypertension and right ventricular function in advanced heart failure","volume":"17","author":"Kalogeropoulos","year":"2011","journal-title":"Congest. Heart Failure (Greenwich, Conn)"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0006","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/CIRCULATIONAHA.111.085761","article-title":"Pulmonary hypertension due to left heart disease","volume":"126","author":"Guazzi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0007","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ahj.2017.06.006","article-title":"Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities","volume":"192","author":"Adir","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0008","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cardfail.2003.12.006","article-title":"Mitral regurgitation in patients with advanced systolic heart failure","volume":"10","author":"Patel","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0002-9149(93)90220-7","article-title":"Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"72","author":"Saxon","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0010","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart diseases","volume":"62","author":"Vachiery","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0011","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00059-005-2696-3","article-title":"Pulmonary hypertension in advanced heart failure","volume":"30","author":"Ghio","year":"2005","journal-title":"Herz"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0012","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ejhf.1202","article-title":"Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study","volume":"20","author":"Iorio","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0013","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0014","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ejhf.1073","article-title":"Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure","volume":"20","author":"Wolsk","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0016","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","article-title":"Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey","volume":"16","author":"van Deursen","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0017","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: assessment of reduction in mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0018","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0019","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCOUTCOMES.113.000221","article-title":"Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study","volume":"6","author":"Smith","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0021","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jchf.2013.05.001","article-title":"Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure","volume":"1","author":"Miller","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0022","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1253\/circj.CJ-11-1288","article-title":"Clinical Significance of Reactive Post-Capillary Pulmonary Hypertension in Patients With Left Heart Disease","volume":"76","author":"Tatebe","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0023","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/postgradmedj-2018-135550","article-title":"Survival rate and predictors of mortality in patients hospitalised with heart failure: a cohort study on the data of Persian registry of cardiovascular disease (PROVE)","volume":"94","author":"Givi","year":"2018","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0024","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/rmed.2003.1440","article-title":"Hyperuricemia as a prognostic factor in pulmonary arterial hypertension","volume":"97","author":"Bendayan","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0026","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1001\/jama.281.18.1714","article-title":"The definition of anemia in older persons","volume":"281","author":"Izaks","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0027","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0028","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0029","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004436","article-title":"Pulmonary effective arterial elastance as a measure of right ventricular afterload and its prognostic value in pulmonary hypertension due to left heart disease","volume":"11","author":"Tampakakis","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0031","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ejhf.192","article-title":"Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension","volume":"17","author":"Dragu","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0032","first-page":"1871","article-title":"Clinical significance of pulmonary arterial capacitance calculated by echocardiography in patients with advanced heart failure","volume":"81","author":"Saito","year":"2017","journal-title":"Circ J Offic J Jpn Circ Soc"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0033","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.13-1510","article-title":"Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure","volume":"145","author":"Pellegrini","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0034","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.860","article-title":"Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC\/ERS guidelines and insights for future changes","volume":"20","author":"Palazzini","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0035","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","article-title":"Executive summary: heart disease and stroke statistics\u20132010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0036","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jacc.2014.01.022","article-title":"Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox","volume":"63","author":"Lavie","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0037","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0038","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.99.13368299","article-title":"Hyperuricaemia in patients with right or left heart failure","volume":"13","author":"Hoeper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0039","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cardfail.2015.05.011","article-title":"Closing the Sex Gap in Advanced Heart Failure: Reality or Illusion","volume":"21","author":"Joseph","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrtlng.2019.10.003_bib0041","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11936-018-0687-y","article-title":"Sex Differences in the Management of Advanced Heart Failure","volume":"20","author":"Crousillat","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.hrtlng.2019.10.003_bib0042","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.hlc.2014.02.022","article-title":"Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China","volume":"23","author":"Liu","year":"2014","journal-title":"Heart Lung Circ"}],"container-title":["Heart &amp; Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956319305138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956319305138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:35:23Z","timestamp":1758954923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956319305138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0147956319305138"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2019.10.003","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of hemodynamics and comorbidities in pulmonary hypertension due to advanced heart failure","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2019.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}